During the past decade, MAC Clinical Research conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 19 clinical trials were completed, i.e. on average, 44.2% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 17 clinical trials were completed. i.e. 77.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MAC Clinical Research" #1 sponsor was "Allergan" with 4 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MAC Clinical Research" #1 collaborator was "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "Anavex Canada Ltd." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "MAC Clinical Research" are "Diabetes Mellitus" (5 trials), "Alzheimer's Disease" (4 trials), "Atopic Dermatitis" (4 trials), "Gastroparesis" (4 trials) and "Psoriasis" (4 trials). Many other conditions were trialed in "MAC Clinical Research" in a lesser frequency.

Most popular intervention types in "MAC Clinical Research" are "Drug" (47 trials), "Other" (5 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "BMS-986165" (3 trials), "Relamorelin" (3 trials), "Lanabecestat" (2 trials) and "Pimavanserin" (2 trials). Other intervention names were less common.

The vast majority of trials in "MAC Clinical Research" are 44 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MAC Clinical Research". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in MAC Clinical Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in MAC Clinical Research, 16 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".